Workflow
and shoulder implants
icon
Search documents
Johnson & Johnson reveals 2025 sales forecast and plans for its orthopedics business
Fastcompany· 2025-10-14 16:43
J&J Chief Financial Officer Joe Wolk said the company was exploring multiple paths for the separation, with a primary focus on a tax-free spin-off, but remained open to other options. Johnson & Johnson on Tuesday raised its 2025 sales forecast after reporting quarterly earnings that topped Wall Street expectations, and announced plans to spin off its orthopedics business into a standalone company. The healthcare conglomerate now expects product revenue of $93.5 billion to $93.9 billion, about $300 million h ...
J&J to spin off orthopedics business, sees 2026 sales growth of over 5%
Yahoo Finance· 2025-10-14 14:55
By Patrick Wingrove (Reuters) -Johnson & Johnson said on Tuesday it plans to separate its orthopedics business into a standalone company named DePuy Synthes within the next 18 to 24 months, marking its second major spinoff in two years as it sharpens focus on higher-growth healthcare segments. J&J also outlined expectations for faster growth into 2026, driven by new drug launches and a strengthened medical devices portfolio, and raised its 2025 sales forecast after reporting quarterly earnings that toppe ...
Earnings live: JPMorgan, BlackRock, Wells Fargo, Johnson & Johnson take spotlight as Q3 earnings kick off
Yahoo Finance· 2025-10-14 11:35
The third quarter earnings season kicked off in earnest on Tuesday as the major Wall Street banks reported their quarterly results. Coming into the quarter, analysts expect S&P 500 companies to report a 7.9% jump in earnings per share during the third quarter, according to FactSet data. If that figure holds, it would mark the ninth straight quarter of positive earnings growth but a deceleration from the 12% earnings growth reported in Q2 of this year. Source: FactSet On Tuesday, the major financial inst ...